Find a Clinical Trial | Pfizer Clinical Trials

Join PfizerLink — a clinical research registry

Get notified about clinical trials that may be right for you — now and over time. Share some information about your health and medical areas of interest. We’ll reach out if a Pfizer clinical trial may be a fit.

Sickle Cell Disease clinical trial

The DREAM study is exploring whether a study medicine can reduce symptoms and improve the overall health of people with Sickle Cell Disease.

Get started

Join a COVID-flu vaccine clinical trial near you

We’re working closely with doctors and scientists to conduct a clinical trial of combined COVID-19 and flu vaccines. See if you qualify.

Learn more

17 trials found for solid tumor

3 trials recruiting

Pfizer Breast Cancer Clinical Trials

Pfizer has several study medicines in development that may have the potential to help people with various types of breast cancer.

Recruiting

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Melanoma, Non-Small-Cell Lung Cancer, Thyroid Cancer, Glioma

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck

A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors

Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Carcinoma, Squamous Cell of Head and Neck, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Pancreatic Ductal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Small Cell Lung Carcinoma

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer, Carcinoma, Squamous Cell of Head and Neck

A Study of SGN-B6A in Advanced Solid Tumors

Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous

A Study of SGN-B7H4V in Advanced Solid Tumors

Ovarian Neoplasms, Peritoneal Neoplasms, Fallopian Tube Neoplasms, Triple Negative Breast Neoplasms, HER2 Negative Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Endometrial Neoplasms, Carcinoma, Non-Small-Cell Lung,

A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

Neoplasms, Non-small-cell Lung Cancer, Melanoma, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma, Urothelial Carcinoma, Colorectal Carcinoma, Ovarian Carcinoma

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Liposarcoma, CRC, Prostate Cancer, Breast Neoplasms, Adenocarcinoma of Lung, Solid Tumors

Male or Female

18+ years

82study location(s)